BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24205397)

  • 1. The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I.
    Mesa-Torres N; Fabelo-Rosa I; Riverol D; Yunta C; Albert A; Salido E; Pey AL
    PLoS One; 2013; 8(8):e71963. PubMed ID: 24205397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition of PTS-1 cargo proteins by Pex5p: implications for protein mistargeting in primary hyperoxaluria.
    Mesa-Torres N; Tomic N; Albert A; Salido E; Pey AL
    Biomolecules; 2015 Feb; 5(1):121-41. PubMed ID: 25689234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I.
    Fernández-Higuero JÁ; Betancor-Fernández I; Mesa-Torres N; Muga A; Salido E; Pey AL
    Adv Protein Chem Struct Biol; 2019; 114():119-152. PubMed ID: 30635080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants.
    Vankova P; Pacheco-Garcia JL; Loginov DS; Gómez-Mulas A; Kádek A; Martín-Garcia JM; Salido E; Man P; Pey AL
    FEBS Lett; 2024 Feb; 598(4):485-499. PubMed ID: 38243391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
    Fargue S; Lewin J; Rumsby G; Danpure CJ
    J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific characterization of alanine: glyoxylate aminotransferase variants associated with primary hyperoxaluria.
    Lage MD; Pittman AM; Roncador A; Cellini B; Tucker CL
    PLoS One; 2014; 9(4):e94338. PubMed ID: 24718375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Cellini B
    Curr Drug Targets; 2016; 17(13):1482-91. PubMed ID: 26931357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
    Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM
    Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ
    J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
    Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1.
    Zhang X; Roe SM; Hou Y; Bartlam M; Rao Z; Pearl LH; Danpure CJ
    J Mol Biol; 2003 Aug; 331(3):643-52. PubMed ID: 12899834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.